Metal-salen complex compound responsive drug and intra-corporeal behavior control system for metal-salen complex compound
AssigneesYoshihiro ISHIKAWA, IHI Corporation
InventorsYoshihiro Ishikawa, Haruki Eguchi
Life of this patent
Estimating the term…
Abstract
A metal-salen complex compound responsive drug, which has an antidotal property capable of neutralizing cytotoxicity of a metal-salen complex compound, and an intra-corporeal behavior control system for the metal-salen complex compound are provided. This metal-salen complex compound responsive drug contains an effective amount of a metal chelating agent to suppress side effects by the metal-salen complex compound.
Claims10
A metal-salen complex compound responsive drug containing an effective amount of a metal chelating agent to suppress side effects of a metal-salen complex compound.
A metal-containing anti-tumor agent responsive drug containing an effective amount of metal chelating agent to suppress side effects of an anti-tumor agent containing metal.
An intra-corporeal behavior control system for a metal-salen complex compound, comprising:
- a step of administering a metal-salen complex compound to a human or an animal;
- a step of externally applying a magnetic field to an affected site tissue and guiding the metal-salen complex compound to the magnetic-field-applied area;
- a step of suspending or terminating the application of the magnetic field;
- and
- a step of administering an effective amount of a metal chelating agent to suppress side effects of the metal-salen complex compound, which are caused by release of the metal-salen complex compound from the affected site tissue and systemic circulation of the metal-salen complex compound due to the suspension or termination of the application of the magnetic field.
Dependencies are inferred from the claim text.